Globe Life (NYSE:GL) Issues Quarterly Earnings Results, Misses Expectations By $0.07 EPS

Posted by Stanley Muller on Oct 21st, 2026

Globe Life (NYSE:GL – Get Free Report) released its quarterly earnings results on Wednesday. The company reported $4.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.91 by ($0.07), Zacks reports. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.56 billion.

Globe Life Stock Performance

NYSE GL traded down $0.39 during trading on Wednesday, hitting $169.33. 472,531 shares of the company’s stock traded hands, compared to its average volume of 537,453. The stock has a market capitalization of $13.01 billion, a price-to-earnings ratio of 11.24 and a beta of 0.44. Globe Life has a 12-month low of $127.85 and a 12-month high of $191.55. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. The business has a 50 day moving average of $170.92 and a 200-day moving average of $166.88.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be issued a $0.33 dividend. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 annualized dividend and a yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is 8.76%.

Analyst Upgrades and Downgrades

Several research analysts have commented on GL shares. Piper Sandler lifted their target price on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a report on Wednesday, July 15th. TD Cowen raised their target price on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Jefferies Financial Group boosted their target price on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, July 10th. JPMorgan Chase & Co. increased their price target on Globe Life from $193.00 to $195.00 and gave the stock an “overweight” rating in a report on Thursday, October 15th. Finally, Keefe, Bruyette & Woods cut their target price on Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $189.56.

View Our Latest Analysis on GL

Insider Buying and Selling at Globe Life

In related news, EVP Michael Majors sold 37,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the completion of the transaction, the executive vice president directly owned 53,518 shares of the company’s stock, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO James Darden sold 50,000 shares of the business’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the sale, the chief executive officer directly owned 58,451 shares in the company, valued at $10,663,215.93. The trade was a 46.10% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 143,650 shares of company stock valued at $25,793,717. 2.11% of the stock is owned by corporate insiders.

Globe Life announced that its Board of Directors has initiated a share buyback plan on Monday, August 10th that permits the company to buy back $2.50 billion in shares. This repurchase authorization permits the company to purchase up to 17.7% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s leadership believes its stock is undervalued.

Globe Life Company Profile

(Get Free Report)

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.